Navigation Links
Lung Cancer Asbestos Victims Center Now Urges Shipyard Workers Diagnosed With Any Type Of Lung Cancer If They Were Exposed To Asbestos
Date:3/28/2013

ctims Center says, "High risk workplaces for asbestos exposure include the US Navy, shipyards, power plants, manufacturing factories, chemical plants, oil refineries, mines, smelters, aerospace manufacturing facilities, demolition construction work sites, railroads, automotive manufacturing facilities, or auto brake shops. With lung cancer caused by asbestos exposure the lung cancer may not show up until decades after the exposure. Many victims never smoked, and never connected their asbestos exposure to their lung cancer. As long as the victim, or their family members can prove the exposure to asbestos, we will do everything possible to help them get what might be significant financial compensation." For more information please call the Lung Cancer Asbestos Victims Center anytime at 866-714-6466.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10550188.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. DrugRisk Center Adds Latest on First of 3,000 Actos Bladder Cancer Trials
2. Moffitt Researchers help lead international efforts that find new genetic links to ovarian cancer
3. More Genetic Insights Into 3 Types of Cancer
4. Dana-Farber Scientists find potential loophole in pancreatic cancer defenses
5. University of Maryland breast cancer research pioneer Dr. Angela Brodie named AACR Academy Fellow
6. Nearly 14 Million Cancer Survivors in U.S.: Report
7. 5 genetic variations increase risk of ovarian cancer
8. York scientists discover driving force behind prostate cancer
9. An international study identifies new DNA variants that increase the risk for cancer
10. TGen and Scottsdale Healthcare help test cancer drug in clinical trial leading to FDA approval
11. Is Early Baldness in Blacks a Clue to Prostate Cancer?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Seattle-based ... have merged to form Camber Collective. Camber Collective provides strategic advisory services ... SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep experience in customer insights, ...
(Date:7/7/2015)... IL (PRWEB) , ... July 07, 2015 , ... ... the only industry group whose board is limited to permit holders. The Medical ... on how to move the industry forward and are committed to making sure ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great time ... so Amica Insurance is sharing some safety tips. , Jean Tapley, senior wellness coordinator ... Leisure activities/sports, , Start slowly. Going from no activity to ...
(Date:7/7/2015)... ... 07, 2015 , ... On June 22nd-26th, 2015, the Cobo ... National Baptist Convention 110th Annual Session of the National Baptist Congress of Christian ... churches and their congregations, medical professionals and health-related organizations, this week long event ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... creative design firm, today announced that TimberNook ( http://www.timbernook.com/ ) has ... campaign, content strategy, and marketing launch package for new camp providers. TimberNook ...
Breaking Medicine News(10 mins):Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2
... 2 Diabetes and High LDL- ... Cholesterol ... ACE/AACE Road Maps, PARSIPPANY, N.J., May 16 Daiichi Sankyo, Inc. (DSI),announced ... combination with metformin- or,sulfonylurea- based therapy, significantly lowers blood glucose (as,measured by A1C) ...
... Patients who feel better live longer, say Mayo Clinic researchers, ... study results released May 15 as part of the 44th ... , Mayo Clinic cancer researcher and the studys lead ... is an independent factor in survival. , Quality of life ...
... tool could allow physicians to determine much sooner if ... -- A simple blood test to check levels of ... how well treatments are working in women with metastatic ... study. , "It can take several weeks, and ...
... HAE: TSX, MONTREAL, May 16 /PRNewswire-FirstCall/ - ... human,proteins for commercialization, announced today that its Chairman ... will present at the,upcoming Rodman & Renshaw 5th ... in the Zephyr Room at Le Meridien Beach ...
... Inc. (Nasdaq: JAZZ ) announced today that Robert ... at two,upcoming investor conferences., Mr. Myers will speak ... London at 9:30 a.m. BST (4:30 a.m. EDT) on,Wednesday, ... Mr. Myers will present at the FBR Capital,Markets Spring ...
... INDIANAPOLIS, May 15 Lung cancer patients,whose histology is ... according to data from a pivotal non-small cell lung ... Eli Lilly and Company,s,ALIMTA(R) (pemetrexed for injection), will be ... of Clinical Oncology (ASCO) in Chicago,Ill., May 30 -- ...
Cached Medicine News:Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 2Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 3Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 4Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 5Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 6Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 7Health News:Cancer patients' quality of life directly relates to their survival 2Health News:Cancer patients' quality of life directly relates to their survival 3Health News:Blood Test Helps Docs Assess Breast Cancer Treatment 2Health News:Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 2Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 4Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 5Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 6Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 7
(Date:7/7/2015)... July 7, 2015 Noting the need to ... policies currently practiced by the rapidly consolidating pharmacy benefit ... today praised Ohio Governor ... new state effort to help pull back the curtain ... "We applaud Governor Kasich for bringing badly-needed reform ...
(Date:7/7/2015)... 7, 2015  Dedicated to promoting wellness and giving ... took the purple pledge in support of Alzheimer,s ... Brain-Awareness Month, a time to shine a purple light ... all the people in our community who are affected ... the disease, and helps mobilize friends, family members, neighbors ...
(Date:7/7/2015)... and BANGALORE , July ... a global technology provider of innovative clinical trial data ... (Industry Standard Research Reports) recent publication named " EDC ... Performance (2015) ". ISR Reports is one of the ... industry, and this report evaluated 22 EDC and eCOA ...
Breaking Medicine Technology:National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... D-Pharm announced today the,completion of a financial round, which ... late stage clinical stroke program. The,financial round combined a rights ... of NIS 28 million. The IPO was oversubscribed and the,unit ... minimum price. The,company,s pre-money valuation was NIS 120 million. , ...
... , , , ... Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a ... patients manage this devastating disease. , , Extavia ... MS to reduce the frequency of clinical exacerbations. The therapy is also ...
Cached Medicine Technology:D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 2D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 3US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 2US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 3US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 5US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 6US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 7
19 gauge x 8 mm with 15 cm high pressure extension tube preattached to a 10C ring control syringe. 3 per box....
Angled, 20 gauge x 25 mm cannula with 30 gauge x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub, angled 45 degrees 2.5 mm from tip. 10 per box....
The moist air humidifying chamber is designed for the infusion of humidified air during phakic fluid air exchange. Sterile single-use. 10 per box. Most popular size or model....
Includes one aluminum Fox eye shield and one eye Garter shield cover. Packaged 50 per box. White only....
Medicine Products: